Colourmax Derind Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.98 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.29%
- Profit Growth 183.48%
- Ebitda 164.56%
- Net Worth 36.97%
- Total Assets -51.35%
About Colourmax Derind
Colourmax Derind Private Limited (CDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 March 2008 and has a history of 16 years and ten months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Dr. Eberle Clever Chemicals India Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.98 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Kumar and Amudha Sampathkumar serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51496TN2008PTC067091
- Company No.
067091
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Colourmax Derind?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Kumar  | Director | 28-Mar-2008 | Current |
| Amudha Sampathkumar | Director | 31-Dec-2012 | Current |
Financial Performance of Colourmax Derind.
Colourmax Derind Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.29% increase. The company also saw a substantial improvement in profitability, with a 183.48% increase in profit. The company's net worth Soared by an impressive increase of 36.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Colourmax Derind?
In 2022, Colourmax Derind had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zsivira Chemie Merk Private LimitedKannan Kumar and Amudha Sampathkumar are mutual person
Iyegate Business Networks LlpKannan Kumar and Amudha Sampathkumar are mutual person
- Fg Pharma Private Limited
Kannan Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Colourmax Derind?
Unlock and access historical data on people associated with Colourmax Derind, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Colourmax Derind, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Colourmax Derind's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
